Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

OREX Insider Trading

OREX | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at OREX provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2008-08-26 04:36 2008-08-21 COOPER GRAHAM K Officer - CFO and Treasurer OPT+S $12.00 8,259 $99,108 0 0.0%
2008-08-26 04:10 2008-08-21 POWELL MICHAEL Director SELL $12.00 10,100 $121,212 31,555 -24.2%
2007-12-28 21:26 2007-12-26 LANCASTER JAMES C JR Officer - VP of Commercial Operations OPT+S $14.98 3,000 $44,930 0 0.0%
2007-12-28 21:23 2007-12-26 LANDBLOOM RONALD P Officer - VP, Medical and Regulatory OPT+S $14.98 5,000 $74,877 0 0.0%
2007-12-28 21:22 2007-12-26 MCKINNEY ANTHONY A Officer - Chief Operating Officer OPT+S $14.97 4,166 $62,385 0 0.0%
2007-12-22 01:51 2007-12-20 COOPER GRAHAM K Officer - CFO and Treasurer OPT+S $14.09 4,000 $56,364 0 0.0%
2007-12-22 01:45 2007-12-20 DUNAYEVICH EDUARDO Officer - Chief Medical Officer OPT+S $14.09 5,000 $70,455 0 0.0%
2007-12-20 02:39 2007-12-17 TOLLEFSON GARY D Director, Officer - President and CEO OPT+S $14.28 15,000 $214,200 0 0.0%
2007-12-01 03:40 2007-11-29 COWLEY MICHAEL A Officer - Chief Scientific Officer SELL $14.28 35,156 $502,123 181,344 -16.2%
2007-11-30 02:16 2007-11-27 MORE ROBERT J 10% owner SELL $14.27 21,000 $299,670 83,975 -20.0%
2007-11-30 02:13 2007-11-27 SCHOEMAKER KATHLEEN K 10% owner SELL $14.27 21,000 $299,670 83,975 -20.0%
2007-11-30 02:09 2007-11-27 DOVEY BRIAN H Director, 10% owner SELL $14.27 21,000 $299,670 83,975 -20.0%
2007-11-30 02:18 2007-11-27 DP V ASSOCIATES LP 10% owner SELL $14.27 21,000 $299,670 83,975 -20.0%
2007-11-30 02:06 2007-11-27 BLAIR JAMES C 10% owner SELL $14.27 21,000 $299,670 83,975 -20.0%
2007-11-30 02:11 2007-11-27 TREU JESSE I 10% owner SELL $14.27 21,000 $299,670 83,975 -20.0%
2007-11-29 04:57 2007-11-26 MCKINNEY ANTHONY A Officer - Chief Operating Officer OPT+S $14.41 4,166 $60,015 0 0.0%
2007-11-29 04:55 2007-11-26 LANDBLOOM RONALD P Officer - VP, Medical and Regulatory OPT+S $14.41 5,000 $72,028 0 0.0%
2007-11-29 04:55 2007-11-26 LANCASTER JAMES C JR Officer - VP of Commercial Operations OPT+S $14.41 3,000 $43,217 0 0.0%
2007-11-22 00:40 2007-11-20 DUNAYEVICH EDUARDO Officer - Chief Medical Officer OPT+S $14.74 5,000 $73,716 0 0.0%
2007-11-22 00:39 2007-11-20 COOPER GRAHAM K Officer - CFO and Treasurer OPT+S $14.74 4,000 $58,973 0 0.0%
2007-11-22 01:51 2007-11-21 Scale Venture Partners II, LP 10% owner SELL $15.00 100 $1,500 2,717,445 0.0%
2007-11-22 01:52 2007-11-21 BOCK LOUIS C Director, 10% owner SELL $15.00 100 $1,500 2,717,445 0.0%
2007-11-21 04:15 2007-11-19 Scale Venture Partners II, LP 10% owner SELL $15.02 2,800 $42,060 2,717,545 -0.1%
2007-11-21 04:16 2007-11-19 BOCK LOUIS C Director, 10% owner SELL $15.02 2,800 $42,060 2,717,545 -0.1%
2007-11-20 05:22 2007-11-16 Scale Venture Partners II, LP 10% owner SELL $15.53 16,142 $250,682 2,720,345 -0.6%
2007-11-20 05:21 2007-11-16 Scale Venture Partners II, LP 10% owner SELL $15.66 30,419 $476,483 2,736,487 -1.1%
2007-11-20 05:23 2007-11-16 BOCK LOUIS C Director, 10% owner SELL $15.53 16,142 $250,682 2,720,345 -0.6%
2007-11-20 05:22 2007-11-16 BOCK LOUIS C Director, 10% owner SELL $15.66 30,419 $476,483 2,736,487 -1.1%
2007-11-17 01:03 2007-11-15 Scale Venture Partners II, LP 10% owner SELL $15.58 1,499 $23,357 2,766,906 -0.1%
2007-11-17 01:03 2007-11-15 Scale Venture Partners II, LP 10% owner SELL $15.59 14,206 $221,418 2,768,405 -0.5%
2007-11-17 01:02 2007-11-14 Scale Venture Partners II, LP 10% owner SELL $15.54 14,813 $230,169 2,782,611 -0.5%
2007-11-17 04:14 2007-11-15 TOLLEFSON GARY D Director, Officer - President and CEO OPT+S $15.68 15,000 $235,250 0 0.0%
2007-11-17 01:05 2007-11-15 BOCK LOUIS C Director, 10% owner SELL $15.58 1,499 $23,357 2,766,906 -0.1%
2007-11-17 01:05 2007-11-15 BOCK LOUIS C Director, 10% owner SELL $15.59 14,206 $221,418 2,768,405 -0.5%
2007-11-17 01:04 2007-11-14 BOCK LOUIS C Director, 10% owner SELL $15.54 14,813 $230,169 2,782,611 -0.5%
2007-05-02 00:24 2007-05-01 MORE ROBERT J 10% owner BUY $12.00 525,000 $6,300,000 104,975 +100.0%
2007-05-02 00:22 2007-05-01 SCHOEMAKER KATHLEEN K 10% owner BUY $12.00 525,000 $6,300,000 104,975 +100.0%
2007-05-02 00:16 2007-05-01 DOVEY BRIAN H Director, 10% owner BUY $12.00 525,000 $6,300,000 104,975 +100.0%
2007-05-01 23:59 2007-05-01 DOMAIN PARTNERS V LP 10% owner BUY $12.00 512,884 $6,154,608 4,443,832 +13.0%
2007-05-01 23:15 2007-05-01 DP V ASSOCIATES LP 10% owner BUY $12.00 12,116 $145,392 104,975 +13.0%
2007-05-02 00:12 2007-05-01 BLAIR JAMES C 10% owner BUY $12.00 525,000 $6,300,000 104,975 +100.0%
2007-05-02 00:19 2007-05-01 TREU JESSE I 10% owner BUY $12.00 525,000 $6,300,000 104,975 +100.0%
2007-05-01 00:46 2007-04-26 WEBER ECKARD Director BUY $12.00 160,000 $1,920,000 810,000 +24.6%
SHOW ENTRIES

How to Interpret $OREX Trades

Not every insider transaction in OREX is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $OREX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for OREX

Insider activity data for OREX is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $OREX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.